Why the study?
This study aimed to explore the association of ACE gene insertion/deletion polymorphisms with left ventricular hypertrophy in Han and Uighur hypertension-OSAHS patients in China.
Is the ACE gene deletion polymorphism associated with left ventricular hypertrophy in patients with hypertension and OSAHS?
Is the ACE gene deletion polymorphism associated with left ventricular hypertrophy in patients with hypertension and OSAHS?
The ACE gene DD genotype is a potential genetic marker for left ventricular hypertrophy in Uighur, but not Han, patients with hypertension and OSAHS.
Ethnic-specific DD genotype-LVH link in Uighur patients should not yet change practice; leaves open prospective validation.
BACKGROUND This study aimed to explore the association of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphisms with left ventricular hypertrophy (LVH) in Han and Uighur hypertension-OSAHS (obstructive sleep apnea hypopnea syndrome) patients in China. MATERIAL AND METHODS A total of 162 Han and 72 Uygur patients with hypertension-OSAHS were independently subdivided into an LVH group and a non-LVH (NLVH) group based on the left ventricular mass index. The insertion/deletion polymorphisms of ACE gene were determined by polymerase chain reaction. The association of ACE gene insertion/deletion polymorphisms with LVH was assessed by chi-squared test. Logistic regression analysis was performed to obtain the odds ratios and 95% confidence intervals for the risk of LVH after adjusting for confounding factors. RESULTS In Uighur patients, the distributions of D allele and DD genotype showed significant differences between the LVH group and the NLVH group. The difference of DD genotype remained significant after multivariate adjustment. In contrast, no significant differences were observed in the distributions of D allele and DD genotype between the LVH group and the NLVH group in Han patients. Moreover, moderate-severe OSAHS was an independent risk factor for LVH. CONCLUSIONS D allele and DD genotype of ACE gene are possible genetic markers for the risk of LVH in Uighur but not Han hypertension-OSAHS patients.
No takes yet. Share an insight, caveat, or question.
Maitikuerban et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: